Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04150497 |
|---|---|
| Brief Title: | Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) |
| First Submitted : | November 1, 2019 |
| First Submitted that Met QC Criteria : | November 1, 2019 |
| First Posted : | November 4, 2019 |
| Last Update Submitted that Met QC Criteria : | September 22, 2023 |
| Last Update Posted : | September 25, 2023 |